Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease... see more

TSX:SZLS - Post Discussion

StageZero Life Sciences Ltd > CEO bot says financial out...
View:
Post by molotov420 on May 16, 2022 9:22pm

CEO bot says financial out...

but they are not coming up on Sedar yet. Ian get on there with your CEO account and hook us up with the deets please.
Comment by molotov420 on May 16, 2022 9:26pm
nevermind they are there now. 1.3M revs...434K from lab and 886K from Clinic
Comment by LithLover on May 16, 2022 9:31pm
$2.6 million gain from revaluation of warrants  Expenses similar amount   Cost of revenues close to revenues.   $1.3 million in revenues with nearly a net 0 quarter with a loss of only 0.01 per share.   Each quarter gets better should be an interesting call tomorrow    
Comment by skier59 on May 16, 2022 9:51pm
With 2 quarters in now, we can see annual sales coming in around $6 million, which should grow as the business continues to expand. Certainly a MC in the $30 to $40million is justified at this point. This SP should be trading atleast in the mid $0.30's soon I would think, and trade in that range until he next quarter.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities